Decreased REM sleep and altered circadian sleep regulation in mice lacking vasoactive intestinal polypeptide

Sleep

Volumn 34, Issue 1, 2011, Pages 49-56

  Hu, Wang Ping ^a,b   Li, Jia Da ^a   Colwell, Christopher S ^c   Zhou, Qun Yong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circadian; EEG; Knock out; Sleep; Vasoactive intestinal polypeptide

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM SLEEP DISORDER; LIGHT DARK CYCLE; MALE; MOUSE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; REM SLEEP; REM SLEEP DEPRIVATION; SLEEP TIME; SLEEP WAKING CYCLE;

EID: 79751470111     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/34.1.49     Document Type: Article

References (42)

1. Fahrenkrug J, Emson PC. Vasoactive intestinal polypeptide: functional aspects. Br Med Bull 1982;38:265-70. (Pubitemid 13239492)
2. Said SI. Vasoactive intestinal peptide. J Endocrinol Invest 1986;9:191-200. (Pubitemid 16076345)
3. Kruisbrink J, Mirmiran M, Van der Woude TP, Boer GJ. Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist or vasoactive intestinal polypeptide on circadian sleep-wake rhythm in the rat. Brain Res 1987;419:76-86. (Pubitemid 17153396)
4. Obal F Jr, Opp M, Cady AB, Johannsen L, Krueger JM. Prolactin, vasoactive intestinal peptide, and peptide histidine methionine elicit selective increases in REM sleep in rabbits. Brain Res 1989;490:292-300.
5. Jimenez-Anguiano A, Baez-Saldana A, Drucker-Colin R. Cerebrospinal fluid (CSF) extracted immediately after REM sleep deprivation prevents REM rebound and contains vasoactive intestinal peptide (VIP). Brain Res 1993;631:345-8.
6. Mirmiran M, Kruisbrink J, Bos NP, Van der Werf D, Boer GJ. Decrease of rapid-eye-movement sleep in the light by intraventricular application of a VIP-antagonist in the rat. Brain Res 1988;458:192-4.
7. Riou F, Cespuglio R, Jouvet M. Endogenous peptides and sleep in the rat III, The hypnogenic properties of vasoactive intestinal peptide. Neuropeptides 1982;2:265-77.
8. Bourgin P, Lebrand C, Escourrou P, et al. Vasoactive intestinal polypeptide microinjections into the oral pontine tegmentum enhance rapid eye movement sleep in the rat. Neuroscience 1997;77:351-60. (Pubitemid 27079607)
9. Reid KJ, Zee PC. Circadian rhythm disorders. Semin Neurol 2009;29:393-405.
10. Welsh DK, Logothetis DE, Meister M, Reppert SM. Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron 1995;14:697-706.
11. Abrahamson EE, Moore RY. Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res 2001;916:172-91. (Pubitemid 32971919)
12. Vosko AM, Schroeder A, Loh DH, Colwell CS. Vasoactive intestinal peptide and the mammalian circadian system. Gen Comp Endocrinol 2007;152:165-75. (Pubitemid 46935157)
13. Gozes I, Lilling G, Glazer R, et al. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J Pharmacol Exp Ther 1995;273:161-7.
14. Colwell CS, Michel S, Itri J, et al. Disrupted circadian rhythms in VIP- and PHI-deficient mice. Am J Physiol Regul Integr Comp Physiol 2003;285:R939-49.
15. Harmar AJ, Marston HM, Shen S, et al. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 2002;109:497-508.
16. Aton SJ, Colwell CS, Harmar AJ, Waschek J, Herzog ED. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci 2005;8:476-83.
17. Brown TM, Colwell CS, Waschek JA, Piggins HD. Disrupted neuronal activity rhythms in the suprachiasmatic nuclei of vasoactive intestinal polypeptide-deficient mice. J Neurophysiol 2007;97:2553-8. (Pubitemid 46411184)
18. Ciarleglio CM, Gamble KL, Axley JC, et al. Population encoding by circadian clock neurons organizes circadian behavior. J Neurosci 2009;29:1670-6.
19. Hu WP, Li JD, Zhang C, Boehmer L, Siegel JM, Zhou QY. Altered circadian and homeostatic sleep regulation in prokineticin 2-deficient mice. Sleep 2007;30:247-56. (Pubitemid 46494399)
20. Li JD, Hu WP, Boehmer L, et al. Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J Neurosci 2006;26:11615-23. (Pubitemid 44772133)
21. Nitz D, Siegel J. GABA release in the dorsal raphe nucleus: role in the control of REM sleep. Am J Physiol 1997;273:R451-5.
22. Ahnaou A, Yon L, Arluison M, et al. Immunocytochemical distribution of VIP and PACAP in the rat brain stem: implications for REM sleep physiology. Ann N Y Acad Sci 2006;1070:135-42. (Pubitemid 44126631)
23. Petit JM, Luppi PH, Peyron C, Rampon C, Jouvet M. VIP-like immunoreactive projections from the dorsal raphe and caudal linear raphe nuclei to the bed nucleus of the stria terminalis demonstrated by a double immunohistochemical method in the rat. Neurosci Lett 1995;193:77-80.
24. el Kafi B, Cespuglio R, Leger L, Marinesco S, Jouvet M. Is the nucleus raphe dorsalis a target for the peptides possessing hypnogenic properties? Brain Res 1994;637:211-21.
25. Riou F, Cespuglio R, Jouvet M. Hypnogenic properties of the vasoactive intestinal polypeptide in rats. C R Seances Acad Sci III 1981;293:679-82. (Pubitemid 12148113)
26. Obal F Jr, Sary G, Alfoldi P, Rubicsek G, Obal F. Vasoactive intestinal polypeptide promotes sleep without effects on brain temperature in rats at night. Neurosci Lett 1986;64:236-40. (Pubitemid 16158434)
27. Bourgin P, Ahnaou A, Laporte AM, Hamon M, Adrien J. Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptors. Neuroscience 1999;89:291-302. (Pubitemid 29049046)
28. Sheward WJ, Naylor E, Knowles-Barley S, et al. Circadian control of mouse heart rate and blood pressure by the suprachiasmatic nuclei: behavioral effects are more significant than direct outputs. PLoS One 2010;5:e9783.
29. Obal F Jr, Payne L, Kacsoh B, et al. Involvement of prolactin in the REM sleep-promoting activity of systemic vasoactive intestinal peptide (VIP). Brain Res 1994;645:143-9. (Pubitemid 24140120)
30. Obal F Jr, Kacsoh B, Alfoldi P, et al. Antiserum to prolactin decreases rapid eye movement sleep (REM sleep) in the male rat. Physiol Behav 1992;52:1063-8.
31. Obal F Jr, Garcia-Garcia F, Kacsoh B, et al. Rapid eye movement sleep is reduced in prolactin-deficient mice. J Neurosci 2005;25:10282-9. (Pubitemid 41636225)
32. Murck H, Guldner J, Colla-Muller M, et al. VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men. Am J Physiol 1996;271:R905-11.
33. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005;437:1257-63. (Pubitemid 41568665)
34. Pace-Schott EF, Hobson JA. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 2002;3:591-605. (Pubitemid 135706668)
35. Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. A neural circuit for circadian regulation of arousal. Nat Neurosci 2001;4:732-8. (Pubitemid 32595412)
36. Deboer T, Vansteensel MJ, Detari L, Meijer JH. Sleep states alter activity of suprachiasmatic nucleus neurons. Nat Neurosci 2003;6:1086-90. (Pubitemid 37186201)
37. Cutler DJ, Haraura M, Reed HE, et al. The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro. Eur J Neurosci 2003;17:197-204. (Pubitemid 36459498)
38. Maywood ES, Reddy AB, Wong GK, et al. Synchronization and maintenance of timekeeping in suprachiasmatic circadian clock cells by neuropeptidergic signaling. Curr Biol 2006;16:599-605.
39. Kotronoulas G, Stamatakis A, Stylianopoulou F. Hormones, hormonal agents, and neuropeptides involved in the neuroendocrine regulation of sleep in humans. Hormones (Athens) 2009;8:232-48.
40. Steiger A. Neurochemical regulation of sleep. J Psychiatr Res 2007;41:537-52. (Pubitemid 46330396)
41. Gottlieb DJ, O'Connor GT, Wilk JB. Genome-wide association of sleep and circadian phenotypes. BMC Med Genet 2007;8 Suppl 1:S9.
42. Xu YL, Reinscheid RK, Huitron-Resendiz S, et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 2004;43:487-97. (Pubitemid 39094676)